Effect of High Glucose on Expression of Glycolytic Enzymes in Cholangiocarcinoma Cells
Keywords:
bile duct cancer, high glucose, glycolytic enzymes, metabolismAbstract
Background and Objective: Most of cholangiocarcinoma (CCA) patients are presented with metastasis which is the major cause of death of CCA patients. Understanding of factors mediated metastasis may lead to a novel treatment for CCA. Cancer cells produced most of their ATP via aerobic glycolysis. Increasing of enzymes in glycolytic pathways were reported in several cancers. The association of high glucose and CCA progression have been demonstrated previously. Thus, the aim of this study was to investigate whether high glucose condition could affect expression of glycolytic enzymes in CCA.
Methods: Three CCA cell lines, KKU-213, -214, and -055, in normal glucose condition (NG; 5.6 mM) were established by sequentially reduced glucose concentration in the media from high glucose (HG; 25 mM) to 5.6 mM. The increase of O-GlcNAcylated proteins was used as the marker indicating adaptation of cells in low or high glucose condition. Expression of glycolytic enzymes were determined using western blot.
Results: Three CCA cell lines, KKU-213, -214, and -055, in NG and HG were successfully established. All NG cells had lower levels of O-GlcNAcylated proteins than HG cells. The western blot analysis of the key regulatory enzymes: HKII, PFK-1, PKM2, LDHA and MCT1 and MCT4 were compared between NG and HG cells. The results showed that HKII and PFK1 were increased in HG cells of both KKU-055 and KKU-213 cells.
Conclusion: High glucose could promote expression of HKII and PFK1 in CCA cells. This may be one of the mechanisms that high glucose activated progression of CCA.
References
Vatanasapt V, Sriamporn S, Vatanasapt P. Cancer control in Thailand. Jpn J Clin Oncol 2002;32 Suppl:S82-91.
Warburg O. On the origin of cancer cells. Science 1956; 123(3191): 309-14.
Thamrongwaranggoon U, Seubwai W, Phoomak C, Sangkhamanon S, Cha'on U, Boonmars T, et al. Targeting hexokinase II as a possible therapy for cholangiocarcinoma. Biochem Biophys Res Commun 2017; 484(2): 409-15.
Thonsri U, Seubwai W, Waraasawapati S, Sawanyawisuth K, Vaeteewoottacharn K, Boonmars T, et al. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis. Histol Histopathol, 2016: 11819.
Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 2012; 57(1): 69-76.
Liu RQ, Shen SJ, Hu XF, Liu J, Chen LJ, Li XY. Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors. Cancer Cell Int 2013; 13(1): 99.
Saengboonmee C, Seubwai W, Wongkham C, Wongkham S. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma. Cancer Epidemiol 2015; 39(3): 274-8.
Phoomak C, Vaeteewoottacharn K, Silsirivanit A, Saengboonmee C, Seubwai W, Sawanyawisuth K, et al. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation. Sci Rep 2017; 7: 43842.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
Saengboonmee C, Seubwai W, Pairojkul C, Wongkham S. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation. Sci Rep 2016; 6: 18995.
